Cachexia Treatment Market

Cachexia Treatment Market - Global Industry Trend Analysis 2015 to 2019 and Forecast 2020 - 2028

Cachexia Treatment Market Segmented By drug class such as Weight Loss Stabilizers, Appetite Stimulants, Progestogens, Corticosteroids, Combination therapies with distribution channels that is Biological Origin, Drug Delivery, Hospitals.

Report ID: PMRREP32250

Report Type: Ongoing

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Report Price


Pre Book

Market Overview

Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.

The COVID-19 pandemic has an impact on several industries. Due to COVID-19 outbreak, the rate of patients visiting the hospitals has declined which contributed to the reduction in the diagnosis rate of cancer patients and patients seeking treatments. Besides, the manufacturing industries are mostly obstructed due to lockdown causing unparalleled technology and transfigure of business model.  These might cause a disturbance in the supply of medicines most commonly imports from China due to global limitations, this is affecting cancer and its associated treatment.

Rising prevalence of cancer cachexia and along with the development of novel therapy for its treatment will drive the cachexia treatment market growth. The increase in the elder population is another major factor which may propel the growth of the global cachexia treatment market.

Also, an increasing patient awareness level and investment of government into the advancement of healthcare facilities are some of the influencing factors for the growth of global cachexia treatment market. However, some factors can restrain the cachexia treatment market growth such as treatment for cachexia is mostly affected by certain adverse effect associated with cachexia therapy.

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get Report Sample

Market Segmentation

Attribute Details
Based on the drug class
  • Weight Loss Stabilizers
  • Appetite Stimulants
  • Progestogens
  • Corticosteroids
  • Combination therapies
  • Others
Based on indications
  • Cancer
  • Chronic kidney disease.
  • congestive heart failure (CHF)
  • Cystic fibrosis.
  • chronic obstructive pulmonary disease (COPD)
  • Rheumatoid arthritis.
Based on the distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
Based on the region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle-East & Africa (MEA)

The global cachexia treatment market is likely to grow over the forecast period with the increasing demand for combination therapy for cancer patients.  Progestogens held the dominant share in the cancer cachexia treatment market in the year 2019. This is mainly due to the effectiveness and safety of progestogen in the cachexia treatment as well as its cost-effectiveness. Comparatively, Progestogens is expected to remain demanding over the next few years owing to its efficacy than others.

Weight loss stabilizers dominate cachexia treatment market due to extreme weight loss occurs in the patients suffering from cancer and physicians recommending weight loss stabilizers to counter the weight loss as well as to improve the quality of life of cancer patients suffering from cachexia. Based on indications, cancer cachexia segment has a larger share in cachexia treatment market, as the prevalence of cachexia in cancer patients is high (60-80%), when compared with COPD or CIF (5% and 15% respectively).

Based on the distribution channels, the hospital pharmacies are expected to be the most profitable segment in the global cachexia treatment market due to the increasing number of hospital footfall for the treatment of cancer.

North America is expected to hold a major share in the cachexia treatment market due to the increasing prevalence of cancer patients. North America is expected to be followed by Europe due to rise cases of a chronic condition such as cancer and an increase in awareness about the cachexia treatment as well as advanced healthcare facilities.

The Asia Pacific is also expected to have a rapid growth in the global cachexia treatment market due to the increased in government initiatives, investment of prominent company as well as advancement in the healthcare facilities.

The key participants operating in the global Cachexia treatment market are Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc., Bristol-Myers Squibb Company, Inc., Helsinn Healthcare S.A., PsiOxus, Purdue Pharma L.P., Eterna Zentaris Inc., Aphios Corporation, Eli Lilly and Company. Aeterna Zentaris Inc, Aphios Corporation, Neurim, Novartis AG, Pernix Therapeutics, Pfizer Inc,   SkyePharma, Sanofi Pasteur, Takeda Pharmaceutical Company, Therapeutics Ltd, and Obexia AG, XBiotech.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

The report covers exhaustive analysis on:

  • Cachexia Treatment Market  Segments
  • Cachexia Treatment Market  Dynamics
  • Historical Actual Market Size, 2015 - 2019
  • Cachexia Treatment Market  Size & Forecast 2020 to 2030
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

For report customisation and delivery information contact our sales representative.

Companies Covered in This Report

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate